Anti- Japanese-Encephalitis-Viral Effects of Kaempferol and Daidzin and Their RNA-Binding Characteristics by Zhang, Ting et al.
Anti- Japanese-Encephalitis-Viral Effects of Kaempferol
and Daidzin and Their RNA-Binding Characteristics
Ting Zhang
., Zhiqiang Wu
., Jiang Du
., Yongfeng Hu, Liguo Liu, Fan Yang*, Qi Jin*
Institute of Pathogen Biology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
Abstract
Background: New therapeutic tools and molecular targets are needed for treatment of Japanese encephalitis virus (JEV)
infections. JEV requires an a-1 translational frameshift to synthesize the NS1’ protein required for viral neuroinvasiveness.
Several flavonoids have been shown to possess antiviral activity in vitro against a wide spectrum of viruses. To date, the
antiviral activities of flavonol kaempferol (Kae) and isoflavonoid daidzin (Dai) against JEV have not been described.
Methodology/Principal Findings: The 50% cytotoxic concentration (CC50) and 50% effective concentration (EC50) against
JEV were investigated in BHK21 cells by MTS reduction. Activity against viral genomic RNA and proteins was measured by
real-time RT-PCR and western blotting. The frameshift site RNA-binding characterization was also determined by
electrospray ionization mass spectrometry, isothermal titration calorimetry and autodocking analysis. EC50 values of Kae and
Dai were 12.6 and 25.9 mM against JEV in cells pretreated before infection, whereas in cells infected before treatment, EC50
was 21.5 and 40.4 mM, respectively. Kae exhibited more potent activity against JEV and RNA binding in cells following
internalization through direct inhibition of viral replication and protein expression, indicating that its antiviral activity was
principally due to direct virucidal effects. The JEV frameshift site RNA (fsRNA) was selected as a target for assaying Kae and
Dai. ITC of fsRNA revealed an apparent Kb value for Kae that was nine fold stronger than that for Dai. This binding was
confirmed and localized to the RNA using ESI-MS and autodock analysis. Kae could form non-covalent complexes with
fsRNA more easily than Dai could.
Conclusions/Significance: Kae demonstrates more potent antiviral activity against JEV than does Dai. The mode of action of
Kae as an anti-JEV agent seems to be related to its ability to inactivate virus by binding with JEV fsRNA.
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Introduction
Viral infections are important public health problems world-
wide, both in developed and developing countries, due to their
morbidity and mortality. Japanese encephalitis virus (JEV) is a
leading member of the mosquito-transmitted flavivirus family, and
is mainly distributed in China, India and Southeast Asia, where it
can cause the central nervous system disease with irreversible
neurological damage in humans [1]. There are 30,000–50,000
cases of human Japanese encephalitis worldwide and 10,000–
15,000 deaths each year. By some estimates, there may be as many
as 75,000 cases each year [2]. JEV is also one of the main causes of
infectious reproductive failure in swine, resulting in significant
economic losses in the pig industry. This virus has a normal
zoonotic transmission cycle between swine or birds and mosqui-
toes. Swine are the main amplifier hosts, from which infected
mosquitoes transmit the virus to humans [3,4].
The single, long open reading frame of the JEV genome
encodes structural proteins (capsid, C), membrane (prM/M), and
envelope (E) and non-structural proteins (NS1, NS2A, NS2B,
NS3, NS4A, NS4B and NS5). JEV NS1 is involved in viral
replication and regulation of the innate immune response. Recent
research has identified that NS1’ (a larger NS1-related protein),
which plays a role in viral neuroinvasiveness, is the product of an
a-1 ribosomal frameshift event that occurs at a conserved Y CCU
UUU slippery heptanucleotide motif near the beginning of the
NS2A gene, and is stimulated by a downstream RNA pseudoknot
structure (a stem-loop structure, shown in Figure S1) [5,6]. The
stability of the stem-loop structure has been correlated with the
efficiency of ribosomal frameshifting. Therefore, it is possible that
small molecules that bind tightly to this sequence may interfere
with the ability of the ribosome to engage the stable pseudoknot
during frameshifting. Thus, the programmed translational frame-
shift site RNA (fsRNA) in the JEV serogroup might be an
attractive target for designing anti-JEV drugs. Considering the
current limited number of therapeutic options for JEV infection
and no clearly effective antiviral agents, in vitro screening of
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development of novel drugs.
Plant-derived flavonoids and dietary isoflavones, a large group
of naturally occurring phenylchromones found in fruits, vegeta-
bles, tea, soy foods, and herbs, have been shown to possess
potential therapeutic benefits in a variety of viral infections using
both in vitro or in vivo models [7,8]. The predominant isoflavones
found in soybeans are the b-glycoside forms (genistin, daidzin and
glyctin) of genistein, daidzein and glycitein, which are not
bioavailable [9,10]. Upon ingestion, small intestinal brush border
membrane enzymes and bacterial b-glycosidases remove the
glycoside group, after which the isoflavones are readily absorbed
and become bioactive. By far, genistein is the most studied soy
isoflavone, and it has been shown to inhibit the infectivity of
enveloped or non-enveloped viruses, as well as single-stranded (ss)
or double-stranded (ds) RNA or DNA viruses [8]. To the best of
our knowledge, no study has investigated the antiviral properties of
daidzin in vivo or in vitro.
Kaempferol, a polyhydric flavonol, is isolated from various plant
sources including tea, broccoli, delphinium, witch-hazel, grape-
fruit, Brussel sprouts, apples, and medicinal herbs. Kaempferol has
been reported to exhibit activity against herpes simplex virus,
influenza viruses (H1N1 and H9N2) and hepatitis B virus under in
vitro conditions [11,12], but until now, the antiviral properties of
kaempferol against JEV have not been described. For these
reasons, a detailed study of dietary kaempferol and daidzin activity
against JEV in BHK21 cells could help to understand better their
antiviral mechanisms and their application in dietary prevention
and treatment of virus infection.
Comprehensive studies on the nature of interactions between
small molecules and DNA/RNA are of fundamental importance
for biomedical and pharmaceutical sciences. For example, several
classes of mRNA domains, collectively referred to as riboswitches,
have been shown to serve as RNA genetic control elements that
sense the concentrations of specific metabolites (i.e. acting as direct
sensors of chemical compounds) [13,14]. Therefore, the conserved
sequence of JEV frameshift site stem-loop was selected to
characterize the interactions between RNA and kaempferol and
daidzin, using electrospray ionization mass spectrometry (ESI-MS)
and isothermal titration calorimetry (ITC). The two ligand
molecules were docked into the RNA using AutoDock 4.0
program.
Results
Cellular Toxicity of Kae and Dai in BHK21 Cells
Cellular toxicity of Kae and Dai were assessed in BHK21 cells
using the cell MTS reduction assay. When confluent monolayers
were exposed to Kae or Dai at concentrations of 50–400 mM for
72 h at 37uC, both agents exhibited a concentration-dependent
inhibition of cell growth compared to controls (Figure 1A, B). The
CC50 of Kae and Dai against BHK21 cells was 230 and 270 mM,
respectively. The maximum non-toxic doses were determined at
180 and 225 mM respectively, and these were used as the highest
doses in the antiviral assays. For comparison, 7-hydroxyflavone
did not show obvious growth inhibitory effects (data not shown).
Antiviral Activity of Kae and Dai Against JEV in BHK21
Cells. The antiviral activity of Kae or Dai against JEV was also
evaluated by MTS assay. When cells were pretreated with Kae or
Dai or their combination for 2 h, and then infected with 0.1 MOI
JEV for 72 h at 37uC, both Kae and Dai exhibited dose-
dependent inhibition of JEV (Figure 1C, D). The EC50 for Kae
was 12.6 mM against JEV and 70% inhibition at 25.7 mM;
whereas for Dai, EC50 and 70% inhibition values were 25.9 and
92.4 mM, respectively (Figure 1C). Viral inhibition rate (VIR) of
combined Kae and Dai at a concentration of 12.5 mM was
59.17%, whereas VIR was 49.5% for Kae and 21.9% for Dai at
the same concentration (Figure 1D). When cells were infected with
0.1 MOI JEV for 2 h, and then treated with Kae, Dai or their
combination (Figure 1E, F) for 72 h, the EC50 and 70% inhibition
for Kae were 21.5 and 45.8 mM, respectively, whereas the EC50
for Dai was 40.4 mM (Figure 1E). The VIR of Kae, Dai and their
combination was 21.5, 6.9 and 25.9%, respectively, at a
concentration of 12.5 mM (Figure 1F). The results demonstrated
that Kae was a more efficient inhibitor of JEV than Dai was.
Moreover, the combination of Kae and Dai was more effective
against JEV infection than either agent alone. In contrast, 7-
hydroxyflavone, which has only one hydroxyl moiety, had no anti-
JEV activity.
When the anti-JEV activity of Kae and Dai was tested by
immunofluorescence assay (IFA), red fluorescence was observed in
early virus-infected BHK21 cells at 24 h (Figure 2A), but not in
healthy control cells (Figure 2B). The number of fluorescence-
positive cells was reduced significantly in cells treated with 25 mM
Kae or Dai compared to the mock-infected group (Figure 2C, D).
Inhibitory Effects of Kae and Dai on JEV mRNA and E and
NS1/NS1’ Protein Expression
Total RNA was extracted from each group of cells treated for
48 h. JEV mRNA levels were determined using SYBR Green real-
time RT-PCR (relative quantification). Kae and Dai inhibited JEV
mRNA transcription of target genes by .14.2% and 27.1%,
respectively, at 48 h pre-treatment group, compared with the
mock-infected group. In pre-infection group, viral RNA replica-
tion was inhibited by 21.6% by Kae and 43.1% by Dai, compared
with the mock-infected group (Figure 3). These findings show that
Kae and Dai play critical roles in inhibition of JEV RNA
replication.
The effect of 25 mM Kae/Dai in each groups on viral E and
NS1/NS1’ proteins was detected by immunoassay with the Li-
COR Odyssey system and quantified using Odyssey infrared
imaging software (Figure 4). When compared with the mock-
infection group, E, NS1 and NS1’ protein expression was inhibited
by .44.8%, 36.8% and 22.1% by Kae, and .70.1%, 35.3% and
57.2% by Dai, respectively, at pre-infection group (Figure 4 A, C).
When cells were pretreated before JEV infection (pre-treatment
group), E, NS1 and NS1’ protein expression was inhibited by
.12.9%, 7.1% and 1.2% by Kae, and .63.2%, 33.3% and
35.5% by Dai, respectively, when compared with the mock-
infection group (Figure 4B, C). It was clear that Kae pre-treatment
before JEV infection inhibited viral protein expression more than
treatment after infection, and more than Dai administered before
or after infection. Moreover, under the same treatment conditions,
the expression level of NS1 and NS1’ proteins was lower than that
of E protein in mock-infected cells. It may be a differential feature
of the virus stains used in the experiment. However, expression of
NS1 and NS1’ was clearly suppressed in cells treated with Kae or
Dai.
No changes in E, NS1 and NS1’ protein expression was
observed in cells treated with 7-hydroxyflavone pre-treatment
group (Figure 4B, C).
Kae and Dai Membrane Translocation and JEV RNA
Binding in Cells. To determine whether Kae and Dai were
able to reach the cytosol, and their binding characteristics with
JEV RNA, the intrinsic fluorescent properties of flavonoids [15]
were utilized to visualize their presence within the cells. Following
2 h incubation with Kae (50 mM), Dai (100 mM) or control solvent
in uninfected cells or cells that had been infected for 24 h, a series
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through the cell membrane and cytosol. A single image of a layer
from the middle of the series illustrated internalization of Kae
(Figure 5). No auto-fluorescence was observed in the mock-
infection group (Figure 5A). In Kae-treated cells, fluorescence was
intense and spread across the entire cell (Figure 5B, C). The
intrinsic fluorescence of Kae observed in cells that had been
infected for 24 h before treatment (Figure 5B) was more intense
than that in uninfected cells (Figure 5C), which suggests that Kae
inhibits viral activity by binding to viral RNA within the cell
Figure 1. Toxicity of Kae and Dai on BHK21 cells and their effects on JEV infection. (A) Growth inhibition curve of Kae on BHK21 cells for
72 h. CC50 was 230 mM. (B) Growth inhibition curve of Dai on BHK21 cells for 72 h. CC50 was 270 mM. (C) Anti-JEV effects of Kae and Dai when cells
were pretreated for 2 h before infection with 0.1 MOI JEV for 72 h. EC50 for Kae and Dai at 72 h were 12.6 and 25.9 mM, respectively. (D) Comparison
of anti-JEV effects of combination treatment with Kae and Dai when cells received combined pretreatment for 2 h, and were then infected with 0.1
MOI JEV for 72 h. (E) Anti-JEV effects of Kae and Dai when cells were infected with 0.1 MOI JEV for 2 h and then treated with Kae or Dai for 72 h. EC50
was 21.5 mM for Kae and 40.4 mM for Dai. (F) Comparison of anti-JEV effects of combination treatment with Kae and Dai when cells were infected with
0.1 MOI JEV for 2 h followed by combination treatment for 72 h. The data represent the means for five replicate samples of three separate
experiments. Kae (black square) or Dai (black circle).
doi:10.1371/journal.pone.0030259.g001
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detected in either Dai- or 7-hydroxyflavone-treated infected or
uninfected cells at any time point (data not shown), indicating that
Dai and 7-hydroxyflavone may have lower transmembrane
permeability and/or intrinsic fluorescence.
Stoichiometry of Kae/Dai and fsRNA of ESI-MS
ESI-MS spectra are used to determine the stoichiometry and
affinity of flavones for DNA/RNA in the presence of 150 mM
monovalent ammonia ions [16]. Figure 6A shows an ESI mass
spectrum obtained from 5 mM fsRNA1 solution. The spectrum
showed a distribution of multiple peaks, with a number of charges,
z=5 and z=4. There were two groups of signals corresponding to
the free fsRNA1 (1208.5
52, 1211.9
52 and 1216.1
52) for the
charge state z=5 and (1510.9
42, 1514.9
42 and 1519.2
42) for the
charge state z=4. The average molecular mass measured from the
main peaks was 6048, 6060 and 6072 Da respectively. Figure 6B
and C also shows an ESI mass spectrum obtained from the mixed
solution of 50 mM Kae/Dai and 10 mM fsRNA1. Besides the
expected multiple negative ions, a mixture of 1:1 (1265.8
52), 2:1
(1323.2
52), 3:1 (1380.4
52), 4:1 (1437.8
52), 5:1 (1494.8
52), 6:1
(1552.0
52) and 7:1 (1609.2
52) ligand–fsRNA1 complexes for the
charge state z=5 and 1:1 (1582.4
42), 2:1 (1658.5
42),
3:1(1725.5
42), 4:1 (1701.5
42) for the charge state z=4 complexes
were detected in the case of Kae (Figure 6B), whereas only 1:1
(1291.8
52 and 1615.0
42) and 2:1 (1375.0
52 and 1674.7
42) ligand–
fsRNA1 complexes were observed with Dai (Figure 6C). Figure 7
shows the ESI-MS spectra containing 10 mM fsRNA2 with 50 mM
Kae/Dai. The ions corresponding to fsRNA2 and the complexes
appeared in the spectra with a charge z=4; the largest
stoichiometric ratio was 5:1 (1712.8
42) for Kae–fsRNA2 com-
plexes and 1:1 (1658.5
42) for Dai, which suggests that Kae and
Dai can both form adducts with fsRNA1 or fsRNA2 in a diverse
stoichiometric ratio. These ESI-MS results demonstrated different
Figure 2. Antiviral effects of Kae and Dai on JEV in IFA. (A) Virus-infected BHK21 cells without Kae or Dai. There were many infected cells (red).
(B) Healthy control BHK21 cells showed no positive fluorescence reaction. (C) Virus-infected BHK21 cells with treated with Kae. There was a marked
reduction in infected cells. (D) Virus-infected BHK21 cells treated with Dai. Bar: 100 mm.
doi:10.1371/journal.pone.0030259.g002
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comparisons between Kae and Dai, the affinity of the ligands for
fsRNA1 and fsRNA2 was characterized by the concentration of
bound ligand for each RNA molecule, as described by Rosu et al.
[16]. The concentration of Kae bound to fsRNA1 and fsRNA2
was 1.901 mM and 1.213 mM for each RNA molecule, which was
higher than that of daidzin (0.686 mM per fsRNA1 and 0.452 mM
per fsRNA2). Thus, Kae has higher binding affinity to fsRNA1
and fsRNA2 than Dai in the presence of ammonia ions.
As a control, we selected a 7-hydroxyflavone displaying no anti-
JEV activity to test its affinity to fsRNA1 and fsRNA2. Increasing
the ratio of 7-hydroxyflavone:fsRNA1 to 80:1 allowed the
detection of complexes of 2:1 7-hydroxyflavone:fsRNA1/fsRNA2
complexes (Figures 6D, 7D), but it had a lower relative abundance
when compared with Kae:fsRNA1/fsRNA2 complexes
(Figures 6B, 7B). We verified that Kae had higher binding affinity
to the fsRNA1 and fsRNA2 than Dai and 7-hydroxyflavone had in
the presence of ammonia ions.
Characterization of Ligand–RNA Interaction by ITC200
Analysis
The interactions of Kae and Dai ligands with fsRNA3 were
studied by the ITC200 method. The fsRNA3 solution was placed at
room temperature for 24 h to obtain a stable stem-loop structure
before the tests. The thermodynamic parameters for the binding of
fsRNA3 obtained at 25uC are summarized in Figure 8. The ITC
data for Dai binding to fsRNA3 (Figure 8A) yielded a Kb of
9.0261.06610
6 M
21,aDH=29.561.19 kcal mol
21,aDSo f
20.05 cal mol
21 K
21, and a binding site size of eight nucleotides.
The value for Kae with fsRNA3 (Figure 8B) had an apparent Kb
of 84.264.24610
6 M
21, which was ninefold stronger than that of
Dai; an enthalpy value of DH=215.9560.47 kcal mol
21, which
decreased obviously compared with that of Dai, and also displayed
a large unfavorable entropic component (217.2 cal mol
21 K
21)
and a binding site size of 2.7 nucleotides. This entropy was ,34-
fold greater in magnitude than that observed for Dai, suggesting
that Kae gave rise to changes in fsRNA3 conformation compared
with Dai. In contrast, there were no constant thermodynamic
parameters between 7-hydroxyfalvone and RNA (data not shown).
Perhaps the use of simpler models is not suitable for 7-
hydroxyflavone binding because the thermogram fit values were
unacceptable.
Characterization of Kae/Dai Binding to RNA by Docking
Study. The computed binding energy (BE) and corresponding
energy difference value (DE) for each group are listed in Tables 1
and 2. A negative value of BE means that the corresponding RNA-
ligand complex is energetically stable; the more negative the BE is,
the more stable the complex is. These quantities reflected the
ability of RNA to bind to Dai (a) and Kae (b). From three fsRNA
docking results (Table 1), the BE of Kae complexes with each
RNA molecule was always lower than that of Dai complexes with
each corresponding RNA molecule. Moreover, the complex of
Kae with R3 molecule had the lowest binding energy in all RNA
docking results. When Kae was docking into R4, with no base ‘G’
in sequence, BE of the Kae–R4 complex increased to
24.14 kcal mol
21, and elevated by 0.9 kcal mol
21 compared to
that of the Kae–R1 complex (25.04 kcal mol
21). This indicated
that base G might influence the binding ability between Kae and
RNA. The top ranked dock conformation for Kae and Dai with
fsRNA is presented in Figure 9. Visualization of the dockings
reveals the top ranked conformation and binding sites which
contain a sequence of three base (CGG or CCG) when ligands are
docked into the fsRNA.
In double stain RNA (dsRNA) docking results, the inclusions
U1a, N1a and N1b had the highest probabilities and largest BE.
The lowest binding energy and frequencies characterizing
inclusion of Dai and Kae into RNA molecules are depicted
separately in Table 2. Most of the complexes of Kae with RNA
molecules with a UUU triplet had a BE that was 1 kcal mol
21
lower than that of RNA duplexes that contained UUU triplets
with Dai. We obtained similar results for the inclusion complexes
of RNA without UUU with Kae and Dai. Visualization of the
dockings reveals that the ligands are docked into the minor groove
of RNA duplexes. The top ranked dock conformation for Kae and
Figure 3. Comparison of the inhibitory effects of 25 mM Kae and Dai on JEV mRNA expression at 48 h. (A) mRNA expression level of JEV-
infected cells (mock infection) was defined as 100%. The amount of viral RNA was normalized by the amount of cellular b-actin transcripts. Mock
infection: infection alone without compound treatment; pretreatment: cell monolayers were pretreated with Kae or Dai for 2 h, and then infected for
48 h; pre-infection: cell monolayers were infected with 0.1 MOI of JEV for 2 h and then treated with Kae or Dai for 48 h. The data represent the means
for five replicate samples of three separate experiments.
doi:10.1371/journal.pone.0030259.g003
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bonds are presented in Figure 10. Dai or Kae remained almost
parallel to the double strand of the minor groove of the RNA
molecule, and there were many hydrogen bond interactions
between RNA and the ligands, as described in the systematic
docking studies. These observations clearly showed that the
Figure 4. Comparison of the inhibitory effects of 25 mM Kae and Dai on JEV E, NS1 and NS1’ protein expression at 48 h. (A) Histogram
of JEV E, NS1 and NS1’ protein expression levels in cells infected and then treated with Kae or Dai. (B) Histogram of viral E, NS nd NS1’ protein
expression levels in cells pretreated with Kae or Dai before infection. (C) Representative western blots of E, NS1 and NS1’ protein expression. The E,
NS1 and NS1’ protein level in JEV-infected cells (mock infection) was defined as 100%. The amount of E, NS1 and NS1’ proteins was normalized to the
amount of cellular b-actin. Mock infection: infection alone without compound treatment; pretreatment: cell monolayers pretreated with Kae or Dai
for 2 h, and then infected for 48 h; preinfection: cell monolayers infected with 0.1 MOI of JEV for 2 h and then treated with Kae or Dai for 48 h, and 7-
hydroxyflavone as treatment control. Data shown were from three independent experiments with the mean and standard errors.
doi:10.1371/journal.pone.0030259.g004
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the other dsRNAs. There were potentially five and seven hydrogen
bonds formed between the two ligands and RNA molecules for
N1a and N1b systems, respectively. The main contributions of
hydrogen bonds in N1a involved binding between C–H groups or
O–H groups of ligand A; and O and N atoms of the G7, U8 and
G9 bases of the corresponding N1 sequences. However, N1b
involved more hydrogen bonding events by C–H or O–H groups
of ligand B and N–H groups or N atoms of the A13, G14 and G15
bases of N1 sequences. The O–H groups of the linking regions in
B play an important role in the interaction by functioning as
hydrogen bond donors to the N atom of the nucleobase located on
the floor of the minor groove of RNA duplexes.
Discussion
Flaviral infections, including JEV, are an important public
health problem in mainland China due to the limited therapeutic
options and unsatisfactory outcomes. Therefore it is necessary to
screen anti-JEV molecules for the development of novel antiviral
therapies. Usually, cell culture monolayers infected with different
DNA or RNA viruses are the most frequently used in vitro models
for determining antiviral activity of natural compounds [17].
Similarly, in the present study, the putative effect of Kae and Dai
against JEV was studied in BHK21 cells. Anti-JEV activity of Kae
and Dai in BHK21 cells was analyzed by MTS reduction assay
differed markedly from each other in different infection time
points, although both agents showed dose-dependent anti-JEV
activity. When cells were pretreated for 2 h and then infected with
JEV infection and incubated for 72 h at 37uC, EC50 against JEV
for Kae and Dai was 12.6 mM (SI=18.2, SI=CC50/EC50) and
25.9 mM (SI=10.4), respectively. The antiviral activity of Kae and
Dai may have been due to inhibition of viral infection or a
reduction in viral replication by modulating cellular functions
through a number of mechanisms. We next studied viral
inactivation in cells that were infected with JEV for 2 h before
treatment with Kae or Dai. EC50 for Kae and Dai was 21.5 and
40.4 mM, respectively, suggesting that they inhibited events
Figure 5. Internalization of Kae in BHK21 cells. Twenty-four-hour-infected cell monolayers and healthy cells grown on confocal dishes were
incubated with 50 mM kae for 2 h. Fluorescence was detected at 480–500 nm after excitation at 405 nm with an argon laser. Images of a single
middle layer from z-stacks are shown. (A) Cells infected with JEV for 24 h and then treated with 0.1% DMSO for 2 h; (B) cells infected with JEV for 24 h
and then treated with Kae for 2 h; (C) cells treated only with Kae for 2 h. Images represent results from at least three individual experiments. Bar:
50 mm.
doi:10.1371/journal.pone.0030259.g005
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that Kae had a more effective and higher SI value (15.8) than Dai
did, suggesting that Kae is a more potent antiviral agent against
JEV, with no toxicity to BHK21 cells. Furthermore, combination
of Kae and Dai was more efficient against JEV infection,
suggesting a possible synergy in the antiviral properties of
flavonoid and isoflavonoid mixtures.
To further characterize the effects of Kae/Dai treatment on the
cellular response to JEV infection, we investigated their effect on
viral genome mRNA and protein expression. The selected NS2A
segment, a relatively conserved region in JEV ssRNA coding
sequence, was measure by real-time RT-PCR. The Kae and Dai
inhibitory effect on JEV mRNA at 48 h suggested that they play
critical roles in inhibition of viral genome replication. Meanwhile,
the effects of 25 mM Kae/Dai on viral E and NS1/NS1’ protein
detected by western blot showed that Kae and Dai both inhibited
protein expression, when compared to the mock-infected group.
Moreover, the inhibitory effect of Kae on JEV protein expression
in cells treated before infection was more potent than that in cells
treated after infection and in cells treated with Dai before and after
infection. This further revealed that Kae was a more potent
antiviral agent than Dai. The expression levels of NS1 and NS1’
proteins were lower than that of E protein in the mock-infected
cells, indicating that the results of protein expression are related to
virus strain. The obvious suppression of NS1’ expression in cells
treated with Kae showed that Kae might inhibit the efficiency of
the a-1 ribosomal frameshift of JEV. As a control, 7-hydroxy-
flavone did not exert any influence on expression of E, NS1 and
NS1’ proteins.
The mechanism by which flavonoids and related isoflavones
inhibit virus infectivity has yet to be fully elucidated. A review of
the current literature has indicated that flavonoids affect virus
binding to cell membranes, entry into the cell, replication, viral
protein translation within the host cell, and formation of certain
glycoprotein complexes of the virus envelope [8]. At the host cell
level, isoflavones, mainly genistein but not daidzein, can affect the
induction of certain transcription factors and secretion of
cytokines; most of these effects have been attributed to a reduction
in protein tyrosine kinase activity [18]. Kae and its derivatives
have been tested for their potential antiviral properties including
reducing herpes simplex virus-1 and poliovirus infection at
0.4 mM and ,10 mM, respectively [19,20]. Previous research
also has shown that Kae possesses antiviral properties against
H1N1/H9N2 viruses by inhibiting neuraminidase activity, and
that flavonoid activity depends on the position and number of
hydroxyl groups on the flavonoid backbone. Activity requires the
presence of 49-OH, 7-OH, C4O, and C2C3 functional groups, but
is markedly reduced by the presence of a glycosyl moiety
[12,21,22]. These intriguing properties were also verified in our
research, in which Kae had greater anti-JEV activity than Dai
Figure 6. ESI-MS full-scan spectra of fsRNA1 (R1, MW, 6048 Da) and its mixtures with 50 mM Kae and Dai. (A) Mass spectrum of 5 mM
RNA alone. RNA solution was prepared by mixing equal volumes of methanol and a 10 mM (150 mM ammonium acetate) solution of RNA; (B) Mass
spectrum offsRNA1 with Kae. The solution was prepared by mixing equal volumes of 50 mM methanol solution of Kae and 10 mM (150 mM
ammonium acetate) solution of fsRNA1; (C) Mass spectrum offsRNA1 with Dai. The solution was prepared by mixing equal volumes of 50 mM
methanol solution of Dai and 10 mM (150 mM ammonium acetate) solution of fsRNA1; (D) Mass spectrum offsRNA1 with 7-hydroxyflavone. The
solution was prepared by mixing equal volumes of 80 mM methanol solution of 7-hydroxyflavone and 10 mM (150 mM ammonium acetate) solution
of fsRNA1. fsRNA1 alone, and 1:1, 2:1, 3:1, 4:1, 5:1, 6:1 and 7:1 complexes are indicated.
doi:10.1371/journal.pone.0030259.g006
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the antiviral properties of Dai have not been described in vivo or in
vitro, which may be attributed to the presence of a glycosyl moiety
that influences antiviral activity. Greiner et al. [23] have
demonstrated that Dai does not alter virus elimination from
serum or affect the immune response of the host in virally
challenged pigs. Dai also resulted in activity against JEV in the
present study, especially in cells pretreated before infection,
suggesting that Dai might share the same binding site of the
target molecule with Kae.
Flavonoids are reported to possess the ability to be internalized
by platelets and cells. The internalization of Kae observed by
confocal microscopy indicated that Kae had high transmembrane
permeability in cells. The higher Kae fluorescence observed in
infected cells compared to uninfected cells indicates that Kae
might bind to JEV RNA. In contrast, no fluorescence was
observed in 7-hydroxyflavone- or Dai-treated infected cells or
control cells at any time point. In particular, 7-hydroxyflavone was
scattered in the extracellular medium, indicating that it has lower
transmembrane permeability and viral RNA binding properties
than Kae have. Generally, flavonoid activity is attributed to the
ability of these compounds to interact with proteins, lipids and
polynucleotides through electrostatic and hydrophobic forces,
which are necessary for biomolecular interaction within cells and
cell–cell interaction, and signal transduction [24,25]. The current
study shows that the high potency of JEV inhibition by Kae,
attributed to its structure, may be achieved through attenuation of
viral mRNA replication and protein expression. In contrast, Dai
may inhibit JEV activities as potently as Kae, involving moderate-
potency inhibition of RNA replication and low-potency inhibition
of protein expression. Proteins within the same pathway blocked
with different potencies by the flavonoids is likely related to
internalization of Kae by cells. Therefore, high transmembrane
permeability and binding characteristics with JEV RNA of Kae
might be related to its antiviral activities.
Several analytical methods have been developed to characterize
small ligand interactions with DNA/RNA, including fluorescence
spectroscopy, nuclear magnetic resonance, and ultraviolet meth-
ods [26–28]. To address the molecular basis for the inhibitory
mechanisms underlying the effects of Kae and Dai against JEV,
flavonoid binding with RNA was further studied by ESI-MS. ESI-
MS is a soft ionization process that was used to detect non-
covalent interactions [29]. Since then, ESI-MS has been extended
to the study of non-covalent interactions between nucleic acids and
ligands as a screening tool for drug discovery [30]. ESI-MS has
been successful due to the fact that it is a powerful and reliable
method that can be used to determine stoichiometry, relative
binding affinities with multiple ligands or targets even at very low
abundance [31,32]. Here, the ESI-MS results demonstrated that
Kae and Dai were both able to form non-covalent complexes with
fsRNA1/fsRNA2, and Kae showed stronger binding affinity with
fsRAN1 and fsRNA2 than Dai did. By comparison, ratios of up to
1:7 and 1:5 were observed in the case of the fsRNA1–Kae and
fsRNA2–Kae complexes, whereas ratios of up to 1:2 were
observed with the fsRNA1–Dai and fsRNA2–Dai complexes.
The fsRNA1–ligand complex showed stronger affinities than
fsRNA2–ligands, indicating that the affinities may depend on
RNA sequence and selectivity of ligands. Furthermore, eight G
bases in fsRNA1 and five in fsRNA2 might contribute to the
binding sites in accordance with the largest stoichiometric ratio.
Figure 7. ESI-MS full-scan spectra of fsRNA2 (R2, MW, 5423 Da) (5 mM) and its mixtures with 50 mM Kae and Dai. (A) RNA alone; (B) with
Kae; (C) with Dai; (D) with 7-hydroxyflavone. The solution was prepared as described above. fsRNA2 alone, and 1:1, 2:1, 3:1, 4:1 and 5:1 complexes are
indicated.
doi:10.1371/journal.pone.0030259.g007
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and detection of intact non-covalent complexes in the gas phase,
which depends on sample solution conditions. In this experiment,
solvation conditions for RNA and a series of mixtures of RNA and
flavonoid compounds were adjusted appropriately (a 5 mM
solution of RNA or mixture of 10 mM RNA and 50 mM flavonoid,
150 mM ammonium acetate, containing an equal volume of
methanol and water, pH 6.8). Here, methanol was beneficial to
dissolution for hydrophobic flavonoids and MS electrospray
conditions. When the ratio of flavonoid:RNA increased from 5:1
to 10:1, ratios of up to 1:8 fsRNA1–Kae complexes were observed.
Moreover, the relative abundance of fsRNA1–Kae complexes (1:1,
1:2, 1:3 and 1:4) increased and that of RNA decreased in MS
(Figure S2). As a control, we selected 7-hydroxyflavone, which
displayed no anti-JEV activity, to test its affinity to fsRNA1 and
fsRNA2. Increasing the ratio of 7-hydroxyflavone:fsRNA1 to 80:1
allowed the detection of 1:2 7-hydroxyflavone:fsRNA1 complexes,
but they had lower relative abundance when compared with Kae–
fsRNA1 complexes. We demonstrated that Kae had higher
binding affinity to fsRNA1 and fsRNA2 than Dai and 7-
hydroxyflavone in the presence of ammonium ions, by using
ESI-MS. Therefore, ESI-MS provided proof for RNA binding
affinity of Kae/Dai.
In the gas phase, the external medium (vacuum) is widely
considered to be hydrophobic. This reinforces the strength of
hydrogen bonds compared to hydrophobic and van der Waals
interactions [33]. Therefore, one must be cautious in the structural
analogy between gas-phase and solution complexes; this is a
general debate in the MS of non-covalent complexes [34]. To
elucidate this problem further, the binding reactions between
RNA and flavonoids in an aqueous phase were studied using ITC.
ITC is an important tool for measuring the thermodynamics of
interactions between small molecules and biopolymers, in which
all binding parameters (n, K, DH and DS) are simultaneously
determined in a single ITC experiment, thus obtaining informa-
tion that cannot be obtained by other methods [35–37]. In our
research, analysis of the ITC measurements revealed two
interactions to be primarily enthalpy driven. An interesting feature
of the thermodynamic data is obvious variation in energies owing
to differences in the structure of the bound ligand molecule. Kae
was confirmed to have stronger interaction with fsRNA3 (49 nt)
compared with that of Dai, which was in accordance with the ESI-
MS results. Usually, hydrogen binding, Van der Waals forces, and
electrostatic and hydrophobic interactions are the main forces
between small molecules and RNA. According to our thermody-
namic results, binding of fsRNA3 was exothermic and driven by a
Figure 8. ITC profile for the binding of fsRNA3 (R3) to Dai (A) and Kae (B) at 256C in 50 mM Tris–HCl buffer containing 150 mM NaCl
and 0.1% DMSO (pH 7.3). The top panels represent the raw data for sequential injection of RNA into the ligands (curves on the bottom) and RNA
dilution control (curves offset for clarity). The bottom panels show the integrated heat data after correcting for the heat of dilution of RNA against the
molar ratio of Kae to RNA. The data (open squares) were fitted to a one-site model and the solid lines represent the best fit of the data.
doi:10.1371/journal.pone.0030259.g008
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small entropy change, in the case of Dai. Dai binding to fsRNA3
might be associated with several non-covalent molecular interac-
tions such as intercalation of the chromophore system on binding/
intercalation to dsRNA through electrostatic and hydrophobic
interactions (DH,0, DS.0). In the case of Kae, the binding of
fsRNA3 was exothermic and driven by favorable enthalpy increase
combined with an entropy decrease. It is likely that Kae binding to
the fsRNA3 pseudoknot structure occurred through a variety of
forces including hydrogen bonding or Van der Waals forces
(DH,0, DS,0), which might have led to considerable distortion
of the fsRNA stem-loop structure, and in turn caused disruption of
the ordered water structure. Previous reports of binding of some
small molecules to tRNA have indicated single binding events. For
example, the interaction of an alkaloid complex with tRNA,
studied by ITC, suggests that the binding of these alkaloid
molecules to the tRNA structure appears to be mostly through
partial intercalation [38]. The characterization of fsRNA3
interacting with Kae or Dai has revealed they are involved in
diverse stages of the viral life cycle, either replication or virus
protein expression.
However, organic solvents (e.g. DMSO or methanol) strongly
influence thermodynamic parameters from ITC because of the
exothermic reaction. Hence, we cannot acquire thermodynamic
parameters for 7-hydroxyflavone and fsRNA under any experi-
mental conditions. Furthermore, it is not worthwhile exploring in
detail the hydrophobic 7-hydroxyflavone.
To further research the two flavonoid compounds binding to
the frameshift site in a sequence- and/or structure-specific
manner, Kae and Dai were docked into RNA using the AutoDock
4.0 program. From three fsRNA docking results (Table 1), the
lower BE of Kae complexes with each RNA molecule indicated
that Kae could form more stable complexes with three fsRNA
than Dai could, which verified the results from ESI and ITC. In
particular, the lower BE in complexes of ligands with fsRNA3
molecules compared with fsRNA1/fsRNA2 demonstrated that
ligand–fsRNA3 complexes more readily formed non-covalent
complexes than ligand–fsRNA1/fsRNA2, which could be attrib-
uted to the stem-loop structure of fsRNA3. The highest affinity of
Kae–fsRNA3 complexes revealed that Kae could maintain the
stability of the stem-loop structure of frameshift RNA. Visualiza-
tion of the dockings reveals that the Kae and Dai are docked into
the minor groove of RNA duplexes, mainly contributing to
hydrogen bonds between the ligands and diverse base sequence of
RNA, which explains the enhanced antiviral effects of combina-
tion treatment with Kae and Dai. Moreover, most hydrogen bonds
involve the base G in the RNA sequence. When Kae was docked
into another R4 sequence without base G, the BE of the Kae–R4
complex increased to 24.64 kcal mol
21, which was elevated by
0.9 kcal mol–1 compared with that of the Kae–fsRNA3 complex.
This indicated that dsRNA and the base G in RNA might
influence the affinity between Kae and RNA.
To verify the results, the eight dsRNAs sequences selected for
the study model were related to a conserved Y CCU UUU
slippery heptanucleotide that is found ahead of an RNA
pseudoknot structure in an a-1 ribosomal frameshift event. The
lowest binding energy (BE, kcal.mol21) and corresponding energy
difference value (DE, kcal.mol-1) for each group reflected the
ability of RNA to bind ligands Dai and Kae. Compared to the
inclusion complexes formed between Kae and dsRNA with UUU
triplets, RNA that excluded UUU exhibited the anticipated
binding propensity to associate with Kae. We found that Kae
Table 1. The binding energies and corresponding DE
a upon the inclusion complex of fsRNA-ligands (a and b).
Ra complex BE(kcal.mol
21) Rb complex BE(kcal.mol
21) DE
d(kcal.mol
21)
R1a 23.18 R1b 23.64 0.46
R2a 23.46 R2b 23.70 0.24
R3a 23.89 R3b 25.04 1.15
BE: binding energy upon complex; DE
d: Energy difference value between Rb and Ra complex; Dai(a); Kae(b); fsRNA1(R1); fsRNA2(R2); fsRNA3(R3); Ra complex: ligand a
binding with R1,R2 and R3, respectively; Rb complex: ligand b binding with R1,R2 and R3, repectively.
doi:10.1371/journal.pone.0030259.t001
Table 2. The binding energies and corresponding DE
a upon the inclusion complex of dsRNA-ligands (a and b).
acomplex BE(kcal.mol
21)
bcomplex BE(kcal.mol
21) DE
d(kcal.mol
21)
U1a 23.94 U1b 24.83 0.89
U2a 23.91 U2b 25.22 1.31
U3a 23.63 U3b 25.17 1.54
U4a 23.88 U4b 25.02 1.14
N1a 24.46 N1b 25.64 1.18
N2a 24.26 N2b 25.32 1.06
N3a 24.05 N3b 25.35 1.30
N4a 23.96 N4b 25.29 1.33
BE: binding energy upon complex; DE
d: Energy difference value between
acomplex and
bcomplex; Dai(a); Kae(b); U1–U4: dsRNA with UUU triplets; N1–N4: dsRNA
without UUU triplets;
acomplex: ligand a binding with U1–U4 and N1–N4, respectively;
bcomplex: ligand b binding with U1–U4 and N1–N4, respectively.
doi:10.1371/journal.pone.0030259.t002
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superior probabilities. Correspondingly, another important con-
clusion can be drawn by comparison with the inclusion complexes
of Dai with RNA duplexes without UUU triplets. It may be
inferred that the structure of inclusion complexes for Dai binding
to RNA molecules without UUU triplets is present in the preferred
binding mode as well.
For instance, the interaction energy for the complex of N1a (BE,
24.46 kcal mol21) decreased markedly compared with that of
U1a ((BE, 23.94 kcal mol21)), corresponding to the lowest BE of
25.64 kcal mol21 for N1b and 24.83 kcal mol21 for U1b. This
phenomenon might be ascribed to the specificity of the structures
of RNA containing UUU triplets and more G bases in the N1
RNA sequence without UUU triplets. Moreover, the specificity
remains when initial structures of the selected RNA fragments
contain more contiguous U base pairs. Therefore, the eight and
nine base pairs are chosen from two RNA fragments, 59-
(UAAAAAAG)2-39 (U5) and 59-(GAUUUUUCG)2-39 (U6), from
the second and third RNA sequences given in this work,
respectively. For example, the lowest BE of U6b was 0.82 kcal -
mol21 lower than that of U6a (EU6a=23.84 kcal mol21,
EU6b=24.66 kcal mol21) even if U5a had a higher frequency
of 54% (PU6b=28%).
Visualization of the docking into the minor groove of RNA
duplexes reveals that Kae and Dai mainly bind dsRNA depending
on hydrogen bonds between ligands and RNA, indicating
preferential binding for Kae or Dai to a stem-loop structure of
the frameshift on JEV RNA. Visualization of the dockings also
reveals that the top ranked conformation and binding sites are
characterized by containing a special sequence of three base (CGG
or AGG) when ligands are docked into the RNA. The inclusion
complexes of Kae with RNA are more stable than those with Dai,
in agreement with the results of ESI-MS and ITC assay, despite
the different measurement principles.
Many flavonoids exert their antiviral effects through rings that
bind to the viral proteins, or interaction with viral RNA and
efficiently blocking viral uncoating. This is the basis of designing
new and more efficient antiviral drugs, and their effectiveness
depends on the mode and affinity of the binding [13,39]. It is
known that cellular function is often triggered by interactions of
Figure 9. Top-ranked docking conformation for Dai (a) and Kae (b) with fsRNA and hydrogen bonds between the ligands and
fsRNA. (A) R1a; (B) R2a; (C) R1b and (D) R2b.
doi:10.1371/journal.pone.0030259.g009
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exhibits high potential as antioxidant chemotherapy [40,41]. The
antiviral activities of these natural products are attributed to the
same mechanism of action. Thus, the difference in binding modes
and affinities of Kae and Dai with fsRNA is important in
understanding the molecular mechanism of their activities.
It is noteworthy that ESI-MS, ITC and docking data for Kae
binding to fsRNA are in excellent agreement with the cell studies.
The binding characteristics obtained for Kae and the relation to
the frameshift structure of RNA suggest that Kae influences
frameshift efficiency in virus-infected cells through interfering with
a downstream RNA pseudoknot structure. Furthermore, Kae
might affect expression of flaviviral NS1’, which is involved in viral
neuroinvasiveness. Therefore, the programmed translational
frameshift site might be the target for Kae as an antiflaviviral drug.
In this study, we investigated the ability of Kae and Dai, two
natural plant extracts, to suppress JEV replication and E viral
protein expression in BHK21 cells. Our results suggest that Kae is
more promising than Dai for its anti-JEV effects. In addition,
further investigations of the binding properties of structurally
different flavonoids to RNA showed that Kae possessed relatively
stronger binding affinity for RNA and formed non-covalent
complexes more easily. Our results may elucidate new aspects of
molecular targets for anti-JEV chemotherapeutics and facilitate
our understanding of flavonoid transport in cells and prediction of
their antiviral activities by focusing on their structural features.
The results are helpful for a better understanding of antiviral
mechanisms and have broad applications in dietary prevention of
viral infectious diseases.
Materials and Methods
Reagents
Kae (C15H10O6 XLogP3,1.9; H-Bond Donor, 4; H-Bond
Acceptor, 6, Mr.286.23) and Dai (C21H20O9, 416.38 g mol
21,3 -
(4-hydroxyphenyl)-7-[(2S,3R,4S, 5S,6R)-3,4,5- trihydroxy-6-(hy-
droxymethyl) oxan-2-yl] oxychromen-4-one) were purchased from
Sigma (St. Louis, MO, USA). For cell experiments, Kae and Dai
were both dissolved in DMSO and finally diluted in culture
medium. To avoid toxicity or interference from the solvent, the
maximum concentration of DMSO in the medium was ,0.1%. A
downstream fsRNA pseudoknot structure, a stem-loop structure,
(fsRNA3, 59 CCUUUUCAGCUGGGCCUUCUGGUGAUGUU
UCUGGCCACCCAGGAAGUCC39, 49 nt, 3555–3604 nt) of
NS1’ ribosomal frameshift event were chemically synthesized and
purified by HPLC (Integrated Biotech Solutions Co. Ltd.). The two
complementary segments of fsRNA3 were also synthesized using the
above methods: fsRNA1 (59 GGGCCUUCUGGUGAUGUUU 39,
MW, 6048 Da) and fsRNA2 (59 GGCCACCCAGGAAGUCC 39,
MW, 5423 Da). fsRNA1, fsRNA2 and fsRNA3 were selected to study
interaction with Kae or Dai.
Cells and Viruses
BHK21 cells (ATCC, USA) were propagated and maintained in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supple-
mented with 10% fetal bovine serum (Gibco), 100 U/ml penicillin
and 100 mg/ml , streptomycin) at 37uC with 5% CO2. The JEV
strain SA 14-14-2 (GenBank accession No. AF315119) used in this
study was stored in our Department of State Key Laboratory for
Molecular Virology and Genetic Engineering (Beijing, China).
JEV was propagated in BHK21 cells and stored at 280uC before
use.
Toxicity in BHK21 Cells
Cellular toxicity of Kae and Dai were tested according to a
previously reported cell viability assay [42]. Monolayers of BHK21
cells in 96-well plates were incubated with Kae or Dai at
concentrations of 5–500 mM in DMEM for 72 h, and 20 ml MTS/
PMS(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium/phenazine methosulfate: Pro-
Figure 10. Top-ranked docking conformation for Dai (a) and Kae (b) with RNA duplex and hydrogen bonds between the ligands
and dsRNA. (A) U1a; (B) N1a; (C) U2b; and (D) N1b.
doi:10.1371/journal.pone.0030259.g010
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absorbance at 490 nm was measured according to the manufac-
turer’s recommendations. Percent of cell cytotoxic effec-
t=[12(At/As)]6100%. At and As indicate the absorbance of
the test substances and the solvent control, respectively. The CC50
values were defined as the concentration that caused 50%
cytotoxicity. Maximum non-toxic dose was determined micro-
scopically by observing morphological changes after 72 h
incubation.
Antiviral Activity Against JEV
Kae and Dai were tested for their antiviral activity against JEV
using the MTS assay with monolayer cultures of BHK21 cells
grown in DMEM. Cells were infected with 0.1 MOI JEV in 96-
wells plates. After 2 h adsorption at 37uC, plates were washed and
the medium replaced with DMEM containing 2% fetal bovine
serum and different concentrations of Kae and Dai. After 72 h,
20 ml MTS/PMS was added and the absorbance measured at
490 nm test wavelength and 690 nm reference wavelength using a
plate reader. Experiments were also performed by incubating with
5–100 mM Kae or Dai for 2 h, and then infecting with 0.1 MOI
JEV. After 72 h incubation at 37uC, absorbance was measured
with the MTS method as described above.
VIR was calculated as (Atv2Acv)/(Acd2Acv)6100%. Atv
represents the absorbance of the test compounds with virus-
infected cells. Acv and Acd represent the absorbance of the virus
and cells control, respectively. The EC50 was calculated by
regression analysis.
IFA
BHK21 cells were grown on 24-well plates. Cell monolayers
were infected with JEV at 0.1 MOI/0.5 ml for 2 h. The solution
was removed and replaced with DMEM containing 50 mM Kae or
Dai. At 24 h after virus inoculation at 37uC under 5% CO2
atmosphere, the cells were rinsed carefully three times with PBS
(pH 7.4) and fixed with 80% acetone for 15 min at room
temperature. After washing three times with PBS (pH 7.4), the
cells were incubated with JEV E-D3 monoclonal antibody (Beijing
Protein Innovation, China) diluted 1:400 in PBS (pH 7.4) at 37uC
for 1 h. After washing with PBS (pH 7.4), the cells were incubated
with the secondary antibody DyLigh594-conjugated goat anti-
mouse IgG (Jackson, USA) diluted 1:200 in PBS (pH 7.4) at 37uC
for 1 h. After washing with PBS (pH 7.4), the cells were stained
with 500 nM DAPI solution for 10 min at room temperature.
After washing three times with PBS (pH 8.0), the plates were
observed by fluorescence microscopy (Nikon, TE2000-U, Japan).
In the follow-up study, 24-well plates were used to test JEV
mRNA and protein expression. The experiment was divided into
four groups with four replicates for each compound: (1) mock
infection group: mock infection for 48 h without compound
treatment; (2) pretreatment group: cell monolayers were pretreat-
ed with 25 mM Kae or Dai for 2 h, and then infected with 0.1
MOI JEV for 48 h; (3) pre-infection group: cell monolayers were
infected with 0.1 MOI JEV for 2 h and then treated with 25 mM
Kae or Dai for 48 h; and (4) normal control group: healthy cells
without any treatment.
Real-time RT-PCR to Test JEV mRNA Expression
The following primers were used: forward, 59-
CCTCCGTCACCATGCCAGT CTTAG-39 and reverse, 59-
TTCGCCATGGTCTTTTTCCTCTCG-39 to amplify a 133-bp
length in the region of nt 3976–4108 in JEV strain genome
sequence, Tm: 56.8uC. This segment was cloned into pGEM-T
Easy vector to construct the standard plasmid, used to obtain a
standard curve. In the 48 h pretreatment or pre-infection group,
viral RNA was extracted from each well by using RNeasy Mini Kit
(Qiagen) according to the manufacturer’s instructions. An RT
reaction was carried out using Superscript First-Strand Synthesis
System (Invitrogen) in a 20-ml reaction mixture using 1–2 mg total
RNA, according to the manufacturer’s protocol. Real time RT-
PCR was conducted using ABI Prism 7000 Real-time PCR
System (Applied Biosystems). Reactions were performed in a 50 ml
volume that contained 2 ml cDNA, 1 ml each primer and 25 ml
Power SYBR Green PCR Master Mix (Applied Biosystems). The
absolute quantity of viral RNA was calculated by using the
standard curve, and melting curve analysis was performed to verify
the authenticity of the amplification.
Western blotting for Expression of JEV E, NS1 and NS1’
proteins in BHK21 Cells
BHK21 cells were grown on 24-well plates. Cell monolayers
were pretreated with 25 mM Kae or Dai or infected with 0.1 MOI
JEV before treatment. After 48 h, JEV E, NS1 and NS1’ proteins
were detected by western blotting. Harvested cells were washed
three times with PBS, lysed on ice in lysis buffer (50 mM Tris–
HCl; 150 mM NaCl; 1% NP-40; 1 mgl
21 each of aprotinin,
pepstatin, and leupeptin; 1 mM each of EDTA, phenylmethylsul-
fonyl fluoride, dithiothreitol, and sodium fluoride; pH 7.4). The
lysates were centrifuged at 10,0006g at 4uC for 15 min and the
supernatant collected and stored at 280uC until use. The protein
content was determined by the Bradford method. Proteins (20 ng)
were mixed with electrophoresis buffer, boiled for 5 min,
separated on 12% SDS-PAGE, and transferred to nitrocellulose
membranes (Amersham). Membranes were blocked with 10% (w/
v) non-fat dried milk in PBS with 0.2% (v/v) Tween-20 (PBST) for
1 h, and incubated overnight with primary mouse anti-JEV E-D3
monoclonal antibody (1:1000; Beijing Protein Innovation, China),
b-actin monoclonal antibodies (1:1000; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and mouse anti-JEV NS1 monoclonal
antibody (1:50; Abcam, Cambridge, MA, USA) diluted in blocking
solution at 4uC. Membranes were rinsed three times with PBST,
and incubated with the secondary goat anti-mouse IgG conjugated
with IRDye700 fluorescein (1:10,000 dilution; LI-COR, USA) for
1 h at room temperature. Membranes were rinsed twice with
PBST and once with PBS again. Subsequent analysis was
performed with a Li-COR Odyssey system and quantified using
Odyssey infrared imaging software, with b-actin as a loading
control.
Transmembrane Permeability
Cell monolayers grown on 35-mm confocal dishes were infected
with 1 MOI JEV for 24 h, and incubated with 50 mM Kae,
100 mM Dai or 0.1% DMSO for 2 h. As a control, cells without
JEV infection were treated with 50 mM Kae or 100 mM Dai for
2 h. The supernatant was removed and cells were washed twice
with PBS buffer. According to the intrinsic fluorescence of
flavonoids, transmembrane permeability of Kae and Dai was
assessed using a confocal microscope (TCS SP5; Leica, Germany).
Fluorescence was excited at 405 nm with an argon laser and
emitted at 480–500 nm. Three dimensional representations of
cells were constructed by the generation of sections in the z-
dimension and compiled into z-stacks.
ESI-MS
ESI-MS was utilized to investigate the binding stoichiometry of
small molecules to fsRNA1 (R1) and fsRNA2 (R2). Mass spectra
were performed on a Thermo Finnigan LTQ Advantage in the
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electrospray source was set to 250uC, and the voltage on the
heated capillary was 11 V. Full scan mass spectra were recorded in
an m/z range from 500 to 2000. The relative intensities of the free
and bound RNA in the mass spectra were assumed to be
proportional to the relative abundances of these species in solution.
ITC
The binding affinities and enthalpies of the fsRNA3 (R3) and
flavonoids relevant to Kae and Dai were measured by an ITC200
calorimeter (Microcal). In the ITC experiment, 8 mM Kae or Dai
was loaded into the cell with 100 or 200 mM RNA in the titrating
syringe, depending on the binding affinities of the compounds.
RNA and flavonoids were dialyzed into the same buffer (50 mM
Tris-HCl, 150 mM NaCl and 0.1% DMSO, pH 7.3). The
titration experiments were performed at 25uC with an initial
0.4-ml injection for 4 s, followed by 20 2-ml injections of 5 s
duration. The spacing between injections was 120 s. The stirring
speed during the titration was 500 rpm. Equilibrium association
constant (Ka) was obtained by fitting experimental data to a ‘‘one
set of sites’’ binding model using the Origin 7 software package
(Microcal). Correction for the enthalpy of RNA dilution was
carried out by subtracting a straight-line linear fit from the last
three data points of the titration, after the interaction had reached
saturation.
Computational Methods
The two ligand molecules were docked into the RNA using the
AutoDock 4.0 program (Scripps Research Institute) to investigate
further the interaction of the two ligands with fsRNA. Each
docking was performed twice and each operation screened 250
conformations that could have been advantageous for docking,
namely each docking could have 500 preferred conformations.
The sequences of the selected three fsRNA (R1, R2 and R3) are
shown in reagents part, in which R1 and R2 were two fragments
of R3 (two arms of a stem-loop structure in fsRNA). The single-
stranded RNA (ssRNA, R4) contained no G base within its
sequence (59-UUUCCUUCUUU UUAUUUUUCUUUC-
CACCCAUUAAUUCC-39), as in the control ssRNA. The three
dimensional structures of target R1, R2, R3 and R4 were
constructed by Accelrys Discovery Studio 2.1. The geometry of the
ligand molecules was taken from NCBI database (http://
pubchem.ncbi.nlm.nih.gov), which based on X-ray structures.
The grid map of 126664666 points and a grid-point spacing of
0.558 A ˚ were used during the docking process. During the dock
processes, the grid map for R/R3 and R1/R2 were
12661266126 and 6661266100 points, and grid-point spacing
for R/R4,R 1 and R2 were 0.436 A ˚, 0.525 A ˚ and 0.508 A ˚,
respectively. The initial structures of the selected eight dsRNA
fragments were the 20 base pairs shown in Table 3, in which, four
RNA sequences contained UUU triplets assigned as U1–U4, and
the others without UUU triplets were assigned as N1–N4,
generated using the Nucgen program of the Amber package
[43]. The ranking functions of the empirical free energies for the
docked configurations have been tested for all docking models
[44]. Notably, it has been recently reported that AutoDock gives
good results for complexes binding nucleic acids [45].
Supporting Information
Figure S1 Predicted frameshift motif and pseudoknot structure
for JEV near the beginning of the NS2A gene.
(TIF)
Figure S2 ESI-MS full-scan spectra of mixtures of fsRNA1 and
Kae at diverse molar ratio of flavonoid:RNA. (A) Mass spectrum
offsRNA1 with Kae at 5:1 molar ratio of Kae:RNA. The solution
was prepared by mixing equal volumes of 50 mM methanol
solution of Kae and 10 mM (150 mM ammonium acetate) solution
of fsRNA1; fsRNA1 alone, and 1:1, 2:1, 3:1, 4:1, 5:1, 6:1 and 7:1
complexes are indicated (B) Mass spectrum offsRNA1 with Kae at
10:1 molar ratio of Kae:RNA. The solution was prepared by
mixing equal volumes of 100 mM methanol solution of Kae and
10 mM (150 mM ammonium acetate) solution of fsRNA1; 1:1, 2:1,
3:1, 4:1, 5:1, 6:1, 7:1 and 8:1 fsRNA1/Kae complexes are
indicated.
(TIF)
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